Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Cocaine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Omeros Corp. gets $4M from NIDA for OMS527 to treat cocaine Disorder
    Omeros Corp. gets $4M from NIDA for OMS527 to treat cocaine Disorder

    13 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250313692503/en/Omeros-Corporation-Receives-Commitment-of-Over-%244-Million-from-NIDA-for-Further-Development-of-the-Companys-OMS527-Program-to-Treat-Cocaine-Use-Disorder

    BUSINESSWIRE
    13 Mar 2025
    Share Share
    SciSparc, Clearmind Patent Psychedelic Combo For Cocaine Addiction
    SciSparc, Clearmind Patent Psychedelic Combo For Cocaine Addiction

    10 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/10/3039647/0/en/SciSparc-Clearmind-Collaboration-Leads-to-Publication-of-Patent-Application-for-Cocaine-Addiction-Psychedelic-Combination-Treatment-in-South-Korea.html

    GLOBENEWSWIRE
    10 Mar 2025
    Share Share
    Clearmind Patents Psychedelic Combo For Cocaine Addiction In Korea
    Clearmind Patents Psychedelic Combo For Cocaine Addiction In Korea

    10 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/10/3039620/0/en/Clearmind-Medicine-Announces-Publication-of-Patent-for-Cocaine-Addiction-Psychedelic-Combination-Treatment-in-South-Korea.html

    GLOBENEWSWIRE
    10 Mar 2025
    Share Share
    Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2
    Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2

    31 Aug 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200831005044/en/Embera-NeuroTherapeutics-Announces-Subject-Dosed-Phase-2

    BUSINESSWIRE
    31 Aug 2020
    Share Share
    Premier Biotech’s Oral Fluid Drug Testing Device Granted FDA Clearance
    Premier Biotech’s Oral Fluid Drug Testing Device Granted FDA Clearance

    07 Mar 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20180307006221/en

    BUSINESSWIRE
    07 Mar 2018
    Share Share
    Camino Pharma Co-Founder Receives $10.8 Million Grant for Dvp of Potential Drug
    Camino Pharma Co-Founder Receives $10.8 Million Grant for Dvp of Potential Drug

    27 Sep 2017

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/camino-pharma-co-founder-receives-108-million-grant-for-development-of-potential-drug-for-cocaine-and-nicotine-addiction-300526404.html

    PR NEWSWIRE
    27 Sep 2017
    Share Share